TNYA

Tenaya Therapeutics, Inc.

• TipRanks·05/18 11:36

  Canaccord Genuity Sticks to Their Buy Rating for Tenaya Therapeutics (TNYA)

• TipRanks·05/18 10:30

  Analysts Offer Insights on Healthcare Companies: ImmunityBio (IBRX) and Tenaya Therapeutics (TNYA)

• TipRanks·05/17 21:05

  Buy Rating Reiterated on Tenaya: Promising TN-401 RIDGE-1 Data, Strong Transgene Expression, and Upcoming Catalysts Support Attractive Risk/Reward

• TipRanks·05/15 19:30

  Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Lineage Therap (LCTX) and RenovoRx (RNXT)

• TipRanks·05/15 15:55

  Analyst Reiterates Buy on Positive TN-401 RIDGE-1 Data Despite Cutting Price Target from $19 to $3

• Benzinga·05/15 14:11

  Tenaya Therapeutics' Gene Therapy Data Highlights Early Heart Rhythm Improvements

• Dow Jones·05/15 11:14

  Tenaya Shares Rise on Positive Data From ARVC Study

• TipRanks·05/15 10:13

  Tenaya reports data from RIDGE-1 Phase 1b/2 clinical trial of TN-401

• Reuters·05/15 10:01

  TENAYA THERAPEUTICS INC - TN-401 ADVERSE EVENTS WERE ASYMPTOMATIC AND SELF-RESOLVED OR RESPONDED TO TREATMENT

• Simply Wall St·05/11 11:33

  Why Tenaya Therapeutics (TNYA) Is Up 26.6% After New TN-401 Data Near-Term Catalysts

• Simply Wall St·05/10 06:32

  Tenaya Therapeutics (TNYA) Valuation Check As TN-401 Gene Therapy Data Approaches ASGCT 2026

• TipRanks·05/10 02:00

  Analysts Are Bullish on These Healthcare Stocks: Tenaya Therapeutics (TNYA), Context Therapeutics (CNTX)

• TipRanks·05/08 18:50

  Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), VistaGen Therapeutics (VTGN) and Prime Medicine, Inc. (PRME)

• TipRanks·05/08 18:40

  Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Knight Therapeutics (OtherKHTRF) and TScan Therapeutics (TCRX)

• TipRanks·05/07 13:57

  Tenaya Therapeutics: Buy Rating Reiterated on Upcoming Gene Therapy Catalysts and Unchanged $5 Price Target